For help on how to get the results you want, see our search tips.
7 results
Medicine type
Accelerated assessment Remove Accelerated assessment filter
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Conditional approval Remove Conditional approval filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Tulinovet
tulathromycin, opinion date: 16/07/2020, Positive, Last updated: 17/07/2020 -
List item
Summary of opinion: Increxxa
tulathromycin, opinion date: 16/07/2020, Positive, Last updated: 17/07/2020 -
List item
Summary of opinion: Rozlytrek
entrectinib, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020 -
List item
Summary of opinion: Rivaroxaban Accord
rivaroxaban, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Libmeldy
autologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human arylsulfatase A gene, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020 -
List item
Summary of opinion: Tecartus
autologous anti-CD19-transduced CD3+ cells, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020 -
List item
Summary of opinion: Lenalidomide Mylan
lenalidomide, opinion date: 15/10/2020, Positive, Last updated: 16/10/2020